Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|4|429-437

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.4, 2014-10, pp. : 429-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population pharmacokinetic–pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents

By  

PEDIATRIC ANESTHESIA, Vol. 25, Iss. 9, 2015-09 ,pp. : 911-923

John Wiley & Sons Inc

Access to resources Recommend Favorite

Premature infants

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. s4, 2015-05 ,pp. : 39-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and developmental features of atypically developing premature infants with no neurological problems

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. s4, 2015-05 ,pp. : 50-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 380-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching from body surface area‐based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 789-800

John Wiley & Sons Inc

Access to resources Recommend Favorite